Cathie Wood’s ARK Invest Loads on Beam Therapeutics, NU Holdings: Debris, Adaptive Biotechnology – ARK Fintech Innovation ETF (ARCA: ARKF), Adaptive Biotechnology (NASDAQ: ADPT)

On Friday, Cathy Wood– Lead Ark Investment A large number of transactions involved Beam Therapeutics Inc. beam,,,,, NU Holdings Ltd. nu,,,,, Mercadolibre Inc. Merleyand Adaptive Biotechnology Company adpt.
Beam Trading
ARK invests through its Ark Genome Revolution ETF arkg and Ark Innovation ETF Aka total of 24,640 shares of Beam Therapeutics were purchased.
This was obtained after the company’s previous acquisition of Beam Therapeutics shares was only a week ago. The value of the transaction is nearly $750,000 calculated based on the latest closing price.
NU Trade
ARK Invest, investing through its ARK Fintech Innovation ETF arkfpurchased 162,143 shares of NU Holdings Ltd. This marks a major investment by fintech companies and reflects ARK’s strategic positioning in the field of dynamic technology.
The transaction, calculated based on the latest closing price, is worth more than $1.75 million.
Meli and Adpt transactions
On the same day, ARK Invest also sold shares of Mercadolibre Inc and Adaptive Biotechnologies Corp. through its ARK Fintech Innovation ETF, and ARK sold 347 shares of Mercadolibre shares.
Meanwhile, through its Ark Genome Revolution ETF, Ark unloaded 8,129 strands of adaptive biotechnology.
Read the next article:
Disclaimer: The content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Ark Investment
Market News and Data Benefits to You by Benzinga API
©2025 benzinga.com. Benzinga does not provide investment advice. all rights reserved.